Types of Cancer We Treat

Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. We provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services, including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Meet Our Doctors
Dr. Sylvia Adams
Our Approach to Breast Cancer Treatment Our Approach to Breast Cancer Treatment
Diagnosis
Breast Cancer Diagnosis
Surgery
Breast Cancer Surgery
Breast Reconstruction
Breast Cancer Breast Reconstruction
Chemotherapy & Other Systemic Therapies
Breast Cancer Chemotherapy & Other Systemic Therapies
Radiation Therapy
Breast Cancer Radiation Therapy

Related News

New Drug Slows Progression of Advanced Breast Cancer
Read Story
Woman Learns of Misdiagnosis After Double Mastectomy
Read Story
Advances in Breast Cancer Screening Save Lives
Read Story
High Risk of Breast Cancer May Suggest Earlier Mammograms
Read Story
New Treatment Helps Fight Triple-Negative Breast Cancer
Read Story
Options for Managing an Increased Risk of Breast Cancer
Read Story
Health Systems on Long Island Expand Cancer Care Programs
Read Story
Patient Navigates Healthcare Disparities with Expert
Read Story
The Genetic Link in Triple-Negative Breast Cancer Explained
Read Story
Immunotherapy Provides New Options for Advanced Cancers
Read Story
Dr. Freya Schnabel Discusses Advances in Breast Cancer
Read Story
One Young Woman’s Journey to a Double Mastectomy
Read Story

Clinical Trials and Research Studies

Phase 3

A phase III multicenter randomized open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive HER2-negative early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]: NATALEE).

Learn More

Phase 2

Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer (IBC)

Learn More

Phase 3

A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH NEOADJUVANT DOXORUBICIN + CYCLOPHOSPHAMIDE FOLLOWED BY PACLITAXEL + TRASTUZUMAB + PERTUZUMAB IN EARLY HER2-POSITIVE BREAST CANCER

Learn More

Phase 1/2

A Phase 1/2 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-001)

Learn More
View All Related Clinical Trials (19)